{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T12:59:20Z","timestamp":1790600360207,"version":"4.1.0"},"reference-count":80,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Direct evidence for a continuous immune-priming defect in laryngeal squamous cell carcinoma (LSCC) remains incomplete. This Review therefore does not treat failed priming as an established LSCC mechanism. Instead, it separates direct LSCC observations from evidence derived from mixed-site head and neck squamous cell carcinoma cohorts and mechanistic studies in other tumors, using this hierarchy to identify supported pathway nodes and unresolved connections. Direct LSCC studies support recurrent loss of MHC class I antigen-processing components, favorable associations between tumor HLA-DR and clinical outcome, accumulation of PD-L2-positive plasmacytoid dendritic cells, remodeling of dendritic cell states, and an association between tumor-cell STING abundance and advanced disease. None of these findings demonstrates antigen-specific priming. Cross-tumor evidence provides mechanistic context for cDC1 cross-presentation, CCR7-dependent migration, tumor-draining lymph-node priming, and functional cGAS-STING signaling, but these links require LSCC-specific validation. We therefore distinguish MHC class I from MHC class II presentation, cross-presentation from tumor-cell HLA-DR expression, lymph-node priming from intratumoral restimulation, and STING abundance from activation, downstream output, and function. Translational priorities are grouped into evidence-based tiers according to the strength of LSCC evidence and intervention tractability. The MHC-I antigen-processing machinery, PD-L2-positive pDC states, and functional cGAS-STING competence merit the earliest LSCC-specific validation, whereas CLEC9A-, XCR1-, and FLT3L-directed cDC1 strategies remain mechanistically compelling but rely mainly on evidence from other tumor systems. Future multicenter studies should incorporate HLA genotype, population diversity, paired tumor and draining-node sampling, functional assays, and bioinformatic or artificial-intelligence integration with external validation. The proposed sensing-low, presentation-deficient, regulatory-DC-dominant, and signal-present but functionally disconnected phenotypes remain research constructs rather than clinical selection tools. The framework is intended to test where priming fails, if it fails at all, without presenting an unproven LSCC-specific pathway as established biology.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1982997","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T12:14:18Z","timestamp":1790597658000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Testing immune priming failure in laryngeal squamous cell carcinoma: direct evidence, unresolved links, and a compartment-resolved framework"],"prefix":"10.3389","volume":"17","author":[{"given":"Wei-Zhe","family":"Hong","sequence":"first","affiliation":[{"name":"Department of Otorhinolaryngology Head and Neck Surgery, Zhongshan Hospital of Traditional Chinese Medicine, Affiliated to Guangzhou University of Traditional Chinese Medicine, Zhongshan","place":["Guangdong, China"]},{"name":"The Tenth Clinical Medical College of Guangzhou University of Traditional Chinese Medicine, Zhongshan","place":["Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guan-Jiang","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology Head and Neck Surgery, Zhongshan Hospital of Traditional Chinese Medicine, Affiliated to Guangzhou University of Traditional Chinese Medicine, Zhongshan","place":["Guangdong, China"]},{"name":"The Tenth Clinical Medical College of Guangzhou University of Traditional Chinese Medicine, Zhongshan","place":["Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Ping","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology Head and Neck Surgery, Zhongshan Hospital of Traditional Chinese Medicine, Affiliated to Guangzhou University of Traditional Chinese Medicine, Zhongshan","place":["Guangdong, China"]},{"name":"The Tenth Clinical Medical College of Guangzhou University of Traditional Chinese Medicine, Zhongshan","place":["Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao-Qing","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology Head and Neck Surgery, Zhongshan Hospital of Traditional Chinese Medicine, Affiliated to Guangzhou University of Traditional Chinese Medicine, Zhongshan","place":["Guangdong, China"]},{"name":"The Tenth Clinical Medical College of Guangzhou University of Traditional Chinese Medicine, Zhongshan","place":["Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2021.105260","article-title":"All HPV-negative head and neck cancers are not the same: analysis of the TCGA dataset reveals that anatomical sites have distinct mutation, transcriptome, hypoxia, and tumor microenvironment profiles","volume":"116","author":"Kim","year":"2021","journal-title":"Oral Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-25-3377","article-title":"Molecular and immune landscape of recurrent and\/or distant metastatic squamous cell carcinoma of the head and neck: an EORTC\/IMMUCAN project","volume":"32","author":"van der Elst","year":"2026","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-0488","article-title":"HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic marker","volume":"66","author":"Ogino","year":"2006","journal-title":"Cancer Res"},{"key":"B4","article-title":"Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in laryngeal squamous cell carcinoma","volume":"47","author":"Zeng","year":"2012","journal-title":"Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi = Chin J Otorhinolaryngol Head Neck Surg"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/tan.14441","article-title":"Immunohistochemical detection of \u201cex novo\u201d HLA-DR in tumor cells determines clinical outcome in laryngeal cancer patients","volume":"98","author":"Prampolini","year":"2021","journal-title":"Hla"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2023.101678","article-title":"High expression of tumor HLA-DR predicts better prognosis and response to anti-PD-1 therapy in laryngeal squamous cell carcinoma","volume":"33","author":"Heng","year":"2023","journal-title":"Transl Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2026.102715","article-title":"Single-cell analysis highlights the significance of malignant cell IFN\/MHC-II for immunotherapy response in head and neck squamous cell carcinoma","volume":"7","author":"Mints","year":"2026","journal-title":"Cell Rep Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.101936","article-title":"Increased tumor-infiltrating plasmacytoid dendritic cells express high levels of PD-L2 and affect CD8+ T lymphocyte infiltration in human laryngeal squamous cell carcinoma","volume":"45","author":"Ji","year":"2024","journal-title":"Transl Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-24-3679","article-title":"Comprehensive single-cell RNA atlas of human laryngeal normal, preneoplastic, and tumorigenic states","volume":"31","author":"Fu","year":"2025","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.129291","article-title":"Single-cell deciphering of the progression trajectories of the tumor ecosystem in laryngeal squamous cell carcinoma","volume":"22","author":"Cai","year":"2026","journal-title":"Int J Biol Sci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15133510","article-title":"Elevated tumor cell-intrinsic STING expression in advanced laryngeal cancer","volume":"15","author":"Viculin","year":"2023","journal-title":"Cancers"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.102100","article-title":"Spatial analysis identifies DC niches as predictors of pembrolizumab therapy in head and neck squamous cell cancer","volume":"6","author":"Oh","year":"2025","journal-title":"Cell Rep Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1848015","article-title":"Cancer-associated fibroblasts and immune remodeling in laryngeal squamous cell carcinoma: evidence and translational perspectives","volume":"17","author":"Hong","year":"2026","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1931000","article-title":"Myeloid-derived suppressor cells in laryngeal squamous cell carcinoma: an underexplored immunosuppressive axis and strategic target for overcoming checkpoint inhibitor resistance","volume":"17","author":"Huang","year":"2026","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s12943-025-02380-0","article-title":"Demystifying the cGAS-STING pathway: precision regulation in the tumor immune microenvironment","volume":"24","author":"Wang","year":"2025","journal-title":"Mol Cancer"},{"key":"B16","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13045-025-01691-5","article-title":"The cGAS-STING pathway in cancer immunity: mechanisms, challenges, and therapeutic implications","volume":"18","author":"Shen","year":"2025","journal-title":"J Hematol Oncol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41590-025-02354-w","article-title":"Cross-presentation of dead cell-associated antigens shapes the neoantigenic landscape of tumor immunity","volume":"27","author":"Lim","year":"2026","journal-title":"Nat Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-024-00785-5","article-title":"Cross-priming in cancer immunology and immunotherapy","volume":"25","author":"Luri-Rey","year":"2025","journal-title":"Nat Rev Cancer"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1016\/j.immuni.2026.07.002","article-title":"CCR7+ activated dendritic cells are essential for spontaneous and immunotherapy-driven anti-tumor immunity","volume":"59","author":"Koufaki","year":"2026","journal-title":"Immunity"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2134-y","article-title":"A conserved dendritic-cell regulatory program limits antitumour immunity","volume":"580","author":"Maier","year":"2020","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2016.06.003","article-title":"Critical role for CD103(+)\/CD141(+) dendritic cells bearing CCR7 for tumor antigen trafficking and priming of T cell immunity in melanoma","volume":"30","author":"Roberts","year":"2016","journal-title":"Cancer Cell"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-026-02419-4","article-title":"Flt3L-mediated tumor cDC1 expansion enhances immunotherapy by priming stem-like CD8+ T\u2009cells in lymph nodes","volume":"27","author":"Lai","year":"2026","journal-title":"Nat Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.ccell.2017.04.003","article-title":"Tumor-residing Batf3 dendritic cells are required for effector T cell trafficking and adoptive T cell therapy","volume":"31","author":"Spranger","year":"2017","journal-title":"Cancer Cell"},{"key":"B24","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.immuni.2025.11.020","article-title":"Positioning and reversible suppression of CCR7+ dendritic cells in perivascular tumor niches shape cancer immunity","volume":"59","author":"Zitti","year":"2026","journal-title":"Immunity"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-24-3239","article-title":"LSD1 inhibition induces MHC-I and dendritic cell activation to promote antitumor immunity in head and neck squamous cell carcinoma","volume":"86","author":"Chakraborty","year":"2026","journal-title":"Cancer Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-24-4383","article-title":"Tumor-specific MHC-II activates CD4+ and CD8+ T cells in head and neck squamous cell carcinoma to boost immunotherapy efficacy","volume":"85","author":"Zhang","year":"2025","journal-title":"Cancer Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41423-021-00741-5","article-title":"Dendritic cells in cancer immunology","volume":"19","author":"Murphy","year":"2022","journal-title":"Cell Mol Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41577-019-0210-z","article-title":"Dendritic cells in cancer immunology and immunotherapy","volume":"20","author":"Wculek","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/nri3712","article-title":"Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny","volume":"14","author":"Guilliams","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-025-02337-x","article-title":"DC subsets and states unraveled across human juxtatumoral and malignant tissues","volume":"27","author":"Mulder","year":"2026","journal-title":"Nat Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"7338","DOI":"10.1038\/s41467-021-27619-4","article-title":"Investigating immune and non-immune cell interactions in head and neck tumors by single-cell RNA sequencing","volume":"12","author":"K\u00fcrten","year":"2021","journal-title":"Nat Commun"},{"key":"B32","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.immuni.2019.11.014","article-title":"Immune landscape of viral- and carcinogen-driven head and neck cancer","volume":"52","author":"Cillo","year":"2020","journal-title":"Immunity"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.cell.2018.01.004","article-title":"NK cells stimulate recruitment of cDC1 into the tumor microenvironment promoting cancer immune control","volume":"172","author":"B\u00f6ttcher","year":"2018","journal-title":"Cell"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1126\/science.aea1200","article-title":"The CARM1 epigenetic enzyme inhibits cross-presenting dendritic cell function in cancer immunity","volume":"393","author":"Zhang","year":"2026","journal-title":"Science"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/s44318-025-00620-z","article-title":"DNGR-1 signalling limits dendritic cell activation for optimal antigen cross-presentation","volume":"44","author":"Buck","year":"2025","journal-title":"EMBO J"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1016\/j.ccell.2026.04.005","article-title":"Dendritic cell redundancy enables priming of anti-tumor CD4+ T cells in pancreatic cancer","volume":"44","author":"Kureshi","year":"2026","journal-title":"Cancer Cell"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20240955","article-title":"Shared pathway of WDFY4-dependent cross-presentation of immune complexes by cDC1 and cDC2","volume":"222","author":"Jo","year":"2025","journal-title":"J Exp Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"4228","DOI":"10.1038\/s41467-025-59341-w","article-title":"Mature tertiary lymphoid structures evoke intra-tumoral T and B cell responses via progenitor exhausted CD4+ T cells in head and neck cancer","volume":"16","author":"Li","year":"2025","journal-title":"Nat Commun"},{"key":"B39","article-title":"Expression of human beta-defensin-2 in laryngeal squamous cell carcinoma and its correlation with CD1a(+) dendritic cells infiltrating in tumor","volume":"44","author":"Ren","year":"2009","journal-title":"Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi = Chin J Otorhinolaryngol Head Neck Surg"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-013-2510-4","article-title":"Expression of selected regulatory molecules on the CD83+ monocyte-derived dendritic cells generated from patients with laryngeal cancer and their clinical significance","volume":"270","author":"Klatka","year":"2013","journal-title":"Eur Arch Otorhinolaryngol Off J Eur Fed Otorhinolaryngol Soc (EUFOS): Affil Ger Soc Otorhinolaryngol - Head Neck Surg"},{"key":"B41","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1080\/00016480802020459","article-title":"Therapeutic influence on circulating and monocyte-derived dendritic cells in laryngeal squamous cell carcinoma patients","volume":"129","author":"Ma","year":"2009","journal-title":"Acta Otolaryngol (Stockh)"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-24-3595","article-title":"Pan-cancer analyses refine the single-cell portrait of tumor-infiltrating dendritic cells","volume":"85","author":"Ma","year":"2025","journal-title":"Cancer Res"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.03.012","article-title":"Expansion and activation of CD103(+) dendritic cell progenitors at the tumor site enhances tumor responses to therapeutic PD-L1 and BRAF inhibition","volume":"44","author":"Salmon","year":"2016","journal-title":"Immunity"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/j.celrep.2019.09.065","article-title":"Cancer-cell-intrinsic cGAS expression mediates tumor immunogenicity","volume":"29","author":"Schadt","year":"2019","journal-title":"Cell Rep"},{"key":"B45","doi-asserted-by":"publisher","first-page":"4342","DOI":"10.1038\/s41467-026-70934-x","article-title":"Pentose phosphate pathway fuels cGAS-STING signalling to boost function of intratumoral conventional dendritic cells","volume":"17","author":"Liu","year":"2026","journal-title":"Nat Commun"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43743-9","article-title":"TET2-mediated tumor cGAS triggers endothelial STING activation to regulate vasculature remodeling and anti-tumor immunity in liver cancer","volume":"15","author":"Lv","year":"2024","journal-title":"Nat Commun"},{"key":"B47","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2024.01.008","article-title":"SMARCAL1 is a dual regulator of innate immune signaling and PD-L1 expression that promotes tumor immune evasion","volume":"187","author":"Leuzzi","year":"2024","journal-title":"Cell"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-23-1078","article-title":"The exonuclease TREX1 constitutes an innate immune checkpoint limiting cGAS\/STING-mediated antitumor immunity","volume":"12","author":"Lim","year":"2024","journal-title":"Cancer Immunol Res"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3724\/abbs.2025209","article-title":"cGAS-STING pathway reprograms macrophage polarization and is highly expressed in responding tumors after neoadjuvant immunotherapy in head and neck carcinoma","volume":"58","author":"An","year":"2026","journal-title":"Acta Biochim Biophys Sin"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2025.333","article-title":"NOVA1 activation modulates the tumor immune microenvironment through STING phosphorylation in head and neck squamous cell carcinoma","volume":"58","author":"Kim","year":"2026","journal-title":"Cancer Res Treat"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pkaf126","article-title":"STING predicts patterns of failure in locally advanced head and neck squamous cell carcinoma","volume":"10","author":"MacNeil","year":"2026","journal-title":"JNCI Cancer Spectr"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2026.102869","article-title":"Targeted inhibition of ATR kinase promotes antitumor immunity in HNSCC through enhanced STING activation and T cell function","volume":"71","author":"da Costa","year":"2026","journal-title":"Transl Oncol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.123790","article-title":"Targeting the LHX1-LDB1 complex restores STING-dependent senescence surveillance and inhibits head and neck cancer progression","volume":"22","author":"Long","year":"2026","journal-title":"Int J Biol Sci"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-025-03368-2","article-title":"Reciprocal regulation between ferroptosis and STING-type I interferon pathway suppresses head and neck squamous cell carcinoma growth through dendritic cell maturation","volume":"44","author":"Li","year":"2025","journal-title":"Oncogene"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202300854","article-title":"Sono-driven STING activation using semiconducting polymeric nanoagonists for precision sono-immunotherapy of head and neck squamous cell carcinoma","volume":"35","author":"Jiang","year":"2023","journal-title":"Adv Mater"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-020-00395-4","article-title":"Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy","volume":"30","author":"Lv","year":"2020","journal-title":"Cell Res"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-2235","article-title":"Combination of the STING agonist MIW815 (ADU-S100) and PD-1 inhibitor spartalizumab in advanced\/metastatic solid tumors or lymphomas: an open-label, multicenter, phase ib study","volume":"29","author":"Meric-Bernstam","year":"2023","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-24-3630","article-title":"Phase I and II clinical studies of the STING agonist ulevostinag with and without pembrolizumab in participants with advanced or metastatic solid tumors or lymphomas","volume":"31","author":"Harrington","year":"2025","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1097\/MOO.0000000000000245","article-title":"Current understanding of the tumor microenvironment of laryngeal dysplasia and progression to invasive cancer","volume":"24","author":"Trivedi","year":"2016","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15041117","article-title":"The genetic and immunologic landscape underlying the risk of malignant progression in laryngeal dysplasia","volume":"15","author":"Chu","year":"2023","journal-title":"Cancers"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-026-04620-0","article-title":"Immunohistochemical characterization of the tumor immune microenvironment in laryngeal premalignancy: insights into early immune alterations in carcinogenesis","author":"Berr\u00edos","year":"2026","journal-title":"Virchows Arch Int J Pathol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25179685","article-title":"A transcriptomic analysis of laryngeal dysplasia","volume":"25","author":"Maffini","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2025.149917","article-title":"Dynamic tumor microenvironment remodeling from laryngeal leukoplakia to carcinoma revealed by single-cell transcriptomics","volume":"979","author":"Liu","year":"2026","journal-title":"Gene"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-020-06403-y","article-title":"European laryngological society position paper on laryngeal dysplasia part I: aetiology and pathological classification","volume":"278","author":"Odell","year":"2021","journal-title":"Eur Arch Otorhinolaryngol Off J Eur Fed Otorhinolaryngol Soc (EUFOS): Affil Ger Soc Otorhinolaryngol - Head Neck Surg"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20250641","article-title":"Radiotherapy induces YTHDF2 in dendritic cells impairing cross-presentation and T cell function","volume":"223","author":"Chen","year":"2026","journal-title":"J Exp Med"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1850654","article-title":"Single-cell RNA sequencing reveals hypoxia-associated stress response signatures in the immune and stromal microenvironment of laryngeal squamous cell carcinoma","volume":"17","author":"Du","year":"2026","journal-title":"Front Immunol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1573635","article-title":"Dendritic cell-based immunotherapy for head and neck squamous cell carcinoma: advances and challenges","volume":"16","author":"Chen","year":"2025","journal-title":"Front Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202207017","article-title":"CCR7 mediated mimetic dendritic cell vaccine homing in lymph node for head and neck squamous cell carcinoma therapy","volume":"10","author":"Xu","year":"2023","journal-title":"Adv Sci"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1126\/science.ady5362","article-title":"Ms4a7 expression in cDC1s determines cross-presentation and antitumor immunity","volume":"390","author":"Xie","year":"2025","journal-title":"Science"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2025-013364","article-title":"Overcoming impaired antigen presentation in tumor-draining lymph nodes facilitates immunotherapy","volume":"13","author":"O\u2019Melia","year":"2025","journal-title":"J Immunother Cancer"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-23-1536","article-title":"Immunogenetic diversity and cancer immunotherapy disparities","volume":"14","author":"de Miranda","year":"2024","journal-title":"Cancer Discov"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2025.08.013","article-title":"Advancing human leukocyte antigen-based cancer immunotherapy: from personalized to broad-spectrum strategies for genetically heterogeneous populations","volume":"11","author":"Oseni","year":"2025","journal-title":"Trends Cancer"},{"key":"B73","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41698-025-00886-w","article-title":"Multi-omics in immunotherapy research for HNSCC: present situation and future perspectives","volume":"9","author":"Liu","year":"2025","journal-title":"NPJ Precis Oncol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s12105-025-01876-x","article-title":"Spatial transcriptomics and artificial intelligence: a scoping review of emerging applications in head and neck pathology","volume":"20","author":"Yousef","year":"2026","journal-title":"Head Neck Pathol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-02978-9","article-title":"A spatial architecture-embedding HLA signature to predict clinical response to immunotherapy in renal cell carcinoma","volume":"30","author":"Kinget","year":"2024","journal-title":"Nat Med"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-24-1270","article-title":"Artificial intelligence can predict personalized immunotherapy outcomes in cancer","volume":"13","author":"Huang","year":"2025","journal-title":"Cancer Immunol Res"},{"key":"B77","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s10555-024-10226-2","article-title":"TRIM-endous functional network of tripartite motif 29 (TRIM29) in cancer progression and beyond","volume":"44","author":"Wu","year":"2025","journal-title":"Cancer Metastasis Rev"},{"key":"B78","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/s41467-017-00101-w","article-title":"TRIM29 promotes DNA virus infections by inhibiting innate immune response","volume":"8","author":"Xing","year":"2017","journal-title":"Nat Commun"},{"key":"B79","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1038\/s41467-024-44745-x","article-title":"Loss of TRIM29 mitigates viral myocarditis by attenuating PERK-driven ER stress response in male mice","volume":"15","author":"Wang","year":"2024","journal-title":"Nat Commun"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202300978","article-title":"Targeted protein upregulation of STING for boosting the efficacy of immunotherapy","volume":"62","author":"Cho","year":"2023","journal-title":"Angew Chem Int Ed Engl"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1982997\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T12:14:19Z","timestamp":1790597659000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1982997\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":80,"alternative-id":["10.3389\/fimmu.2026.1982997"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1982997","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"article-number":"1982997"}}